Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]open access
- Issue Date
- 2025
- Publisher
- DOVE MEDICAL PRESS LTD
- Keywords
- Amfebutamone; Amine Oxidase (flavin Containing); C Reactive Protein; Insulin; Naltrexone; Amfebutamone Plus Naltrexone; Amfebutamone; Amine Oxidase (flavin Containing); C Reactive Protein; High Density Lipoprotein Cholesterol; Insulin; Low Density Lipoprotein Cholesterol; Monoamine; Naltrexone; Triacylglycerol; Amfebutamone Plus Naltrexone; Blood Pressure; Cardiovascular Risk; Clinical Trial (topic); Heart Rate; Human; Letter; Lipid Blood Level; Medical Practice; Mental Disease; Obesity; Phase 3 Clinical Trial (topic); Quality Of Life; Waist Circumference; Drug Therapy; Note
- Citation
- Drug Design, Development and Therapy, v.19, pp 65 - 66
- Pages
- 2
- Indexed
- SCIE
SCOPUS
- Journal Title
- Drug Design, Development and Therapy
- Volume
- 19
- Start Page
- 65
- End Page
- 66
- ISSN
- 1177-8881
- Abstract
- [No abstract available]
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Natural Science > Department of Statistics > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Ahn, Hong Yup
- College of Natural Science (Department of Statistics)